VM
HRMY icon

Valor Management’s Harmony Biosciences HRMY Stock Holding History

Valor Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Buy
818,013
+700,883
+598% +$22.1M 0.03% 4
2026
Q1 		$3.28M Hold
117,130
– – 1.81% 4
2025
Q4 		$4.38M Sell
117,130
-1,151,074
-91% -$37.8M 7.95% 2
2025
Q3 		$35M Sell
1,268,204
-5,349,829
-81% -$184M 51.91% 1
2025
Q2 		$209M Hold
6,618,033
– – 87.82% 1
2025
Q1 		$220M Hold
6,618,033
– – 91.3% 1
2024
Q4 		$228M Sell
6,618,033
-4,600,000
-41% -$158M 91.4% 1
2024
Q3 		$449M Hold
11,218,033
– – 94.55% 1
2024
Q2 		$338M Hold
11,218,033
– – 74.43% 1
2024
Q1 		$377M Hold
11,218,033
– – 78.55% 1
2023
Q4 		$362M Hold
11,218,033
– – 99.55% 1
2023
Q3 		$368M Hold
11,218,033
– – 98.94% 1
2023
Q2 		$395M Hold
11,218,033
– – 98.29% 1
2023
Q1 		$366M Hold
11,218,033
– – 96.46% 1
2022
Q4 		$618M Hold
11,218,033
– – 97.5% 1
2022
Q3 		$497M Hold
11,218,033
– – 95.45% 1
2022
Q2 		$547M Hold
11,218,033
– – 96.54% 1
2022
Q1 		$546M Hold
11,218,033
– – 83.25% 1
2021
Q4 		$478M Buy
+11,218,033
New +$447M 76.2% 1

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Valor Management's HRMY Position: Q2 2026 in Review

Valor Management increased its Harmony Biosciences (HRMY) stake by 598% in Q2 2026, buying an estimated $22.1M and bringing the position to 818,013 shares worth $29.8M. The position accounts for 0.03% of the portfolio, ranked #4.

Valor Management first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $618M in Q4 2022. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Valor Management held 818,013 shares of Harmony Biosciences worth $29.8M as of Q2 2026.
  • Valor Management bought 700,883 Harmony Biosciences shares in Q2 2026, an estimated $22.1M.
  • Harmony Biosciences made up 0.03% of Valor Management's portfolio in Q2 2026, its #4 holding.
  • Valor Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • Valor Management's Harmony Biosciences position peaked at $618M in Q4 2022.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Valor Management's 13F filing for Q2 2026, filed 14 Aug 2026.